Upregulation of Thrombin/Matrix Metalloproteinase-1/Protease-Activated Receptor-1 Chain in Proliferative Diabetic Retinopathy

Tumor MMP-1 Activates Endothelial PAR1 to Facilitate Vascular Intravasation and Metastatic Dissemination

(2013) A. Juncker-Jensen et al.   CANCER RESEARCH

Advanced Glycation End Products and Diabetic Retinopathy

(2013) M. Chen et al.   CURRENT MEDICINAL CHEMISTRY

Matrix metalloproteases and PAR1 activation

(2012) K. M. Austin et al.   BLOOD

Treatment of proliferative diabetic retinopathy with anti-VEGF agents

(2011) Aysha Salam et al.   ACTA OPHTHALMOLOGICA

PAR-1 and Thrombin: The Ties That Bind the Microenvironment to Melanoma Metastasis

(2011) M. Zigler et al.   CANCER RESEARCH

Identification of a Metalloprotease-Chemokine Signaling System in the Ovarian Cancer Microenvironment: Implications for Antiangiogenic Therapy

(2010) A. Agarwal et al.   CANCER RESEARCH

Thrombin Mediates Severe Neurovascular Injury During Ischemia

(2010) Bo Chen et al.   STROKE

Up-regulation of protease-activated receptor-1 in diabetic glomerulosclerosis

(2009) Takumi Sakai et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Comprehensive Analysis of Inflammatory Immune Mediators in Vitreoretinal Diseases

(2009) Takeru Yoshimura et al.   PLoS One

Relative Importance of Proteinase-Activated Receptor-1 Versus Matrix Metalloproteinases in Intracerebral Hemorrhage-Mediated Neurotoxicity in Mice

(2009) Mengzhou Xue et al.   STROKE

Matrix Metalloproteinase-1 and Thrombin Differentially Activate Gene Expression in Endothelial Cells via PAR-1 and Promote Angiogenesis

(2008) Jessica S. Blackburn et al.   AMERICAN JOURNAL OF PATHOLOGY

Thrombin mediates mitogenesis and survival of human endothelial cells through distinct mechanisms

(2008) Panagiota Zania et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Contributions of multiple proteases to neurotoxicity in a mouse model of intracerebral haemorrhage

(2008) Mengzhou Xue et al.   BRAIN

Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model

(2008) S. M. Eck et al.   BREAST CANCER RESEARCH AND TREATMENT

Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer

(2008) A. Agarwal et al.   MOLECULAR CANCER THERAPEUTICS